CDC owns patent on Ebola virus.

This agreement dates back more than a decade, with Crucell entering Stage I clinical trials for said vaccine back 2006. Several years afterwards, the NIH and NIAID awarded Crucell with further funding to advance the advancement of a multivalent filovirus vaccine to take care of not only Ebola but other very similar viral infections that cause severe hemorrhagic fever in both human beings and non-human primates. The task on an Ebola virus [vaccine], sanctioned by the holder of the patent for the vaccine, the NIH.Population by the entire year 2030, relating to U.S. Census Bureau estimates. Related StoriesAmgen, Novartis collaborate for Alzheimer's disease and migraine programsHealthy adults who receive flu vaccination also may help protect older adults in higher risk for flu-related complicationsNew tool can help diagnose and deal with Parkinson's disease in first stages While previous data possess indicated that aged people show considerably greater impairments than youthful adults when alcoholic beverages is consumed, understanding the neurobiology underlying that elevated sensitivity in the aged offers been hampered by having less an adequate pet model, stated Matthews, a study scientist in psychology and neuroscience in Baylor's University of Arts & Sciences and head of psychology in Nanyang Technological University in Singapore.